PYXS vs TYL · rev $2.8M vs P/E 89, rev $1.26B
Pyxis Oncology Inc (PYXS) versus Tyler Technologies Inc (TYL) — a side-by-side from cached financials, not a winner call.
Pyxis Oncology Inc (PYXS) is a biotechnology company listed on NASDAQ.
Tyler Technologies Inc (TYL) is a software - application company listed on US.
Latest reported PYXS revenue for 2025-09-30 was $2.8M. Net income was -$22.0M. Revenue was up 0.0% from 2025-06-30 to 2025-09-30. PYXS currently screens at market cap $109.6M.
Latest reported TYL revenue for 2026-06-30 was $1.26B. Net income was $174.7M. TYL currently screens at market cap $25.57B and trailing P/E 89.3.
PYXS currently screens at market cap $109.6M. TYL currently screens at market cap $25.57B and trailing P/E 89.3.
Not investment advice. Open the PYXS and TYL stock pages for the full models.
Not investment advice.